These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Reported results||2010-019552-50||Dose-escalation-, PK- and safety study with single agent CetuGEXTM in patients with EGFR positive locally advanced and/or metastatic cancer||2013-11-14||due-trials|
|Reported results||2012-003006-27||A Phase II, Multicentre, Multinational, Randomised, Assessor-Blind Trial to Investigate the Efficacy and Safety of Various Dosages of FSH-GEX™ in Comparison With 150 IU Gonal-f® in Women Undergoing IC...||2013-07-30||due-trials|
|Listed as ongoing, but also has a completion date||2013-000931-28||A Double-blind, Placebo-controlled, Randomized, Phase 2 Study to Evaluate the Efficacy and Safety of Maintenance Therapy With PankoMab-GEX™ After Chemotherapy in Patients With Recurrent Epithelial Ova...||2017-08-15||bad-data|
|Not reported||2013-003695-13||Randomized, controlled, open label, multicenter, phase II study to evaluate the efficacy and safety of CetuGEX™ plus chemotherapy in comparison to cetuximab plus chemotherapy for the treatment of pati...||2017-09-30||due-trials|